T-cell ligands modulate the cytolytic activity of the CD33/CD3 BiTE antibody construct, AMG 330
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology
Link
http://www.nature.com/articles/bcj201568.pdf
Reference40 articles.
1. Carter P . Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer 2001; 1: 118–129.
2. Riethmüller G . Symmetry breaking: bispecific antibodies, the beginnings, and 50 years on. Cancer Immun 2012; 12: 12.
3. Baeuerle PA, Reinhardt C . Bispecific T-cell engaging antibodies for cancer therapy. Cancer Res 2009; 69: 4941–4944.
4. Choi BD, Cai M, Bigner DD, Mehta AI, Kuan CT, Sampson JH . Bispecific antibodies engage T cells for antitumor immunotherapy. Expert Opin Biol Ther 2011; 11: 843–853.
5. Topp MS, Gökbuget N, Zugmaier G, Degenhard E, Goebeler ME, Klinger M et al. Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL. Blood 2012; 120: 5185–5187.
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mechanisms of resistance against T-cell engaging bispecific antibodies in multiple myeloma: implications for novel treatment strategies;The Lancet Haematology;2024-09
2. Targeting the membrane-proximal C2-set domain of CD33 for improved CAR T cell therapy;Molecular Therapy: Oncology;2024-09
3. Bispecific antibodies: advancing precision oncology;Trends in Cancer;2024-08
4. CD28 co-stimulation: novel insights and applications in cancer immunotherapy;Nature Reviews Immunology;2024-07-25
5. Facile Access to Branched Multispecific Proteins;Bioconjugate Chemistry;2024-06-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3